Ashleigh Porter, M.D.

Provider Type: Physician

Specialties:

Hematology
Medical Oncology

Board Certifications:

Hematology
Internal Medicine
Medical Oncology

Texas Oncology-Cedar Park
1401 Medical Pkwy., Building C, Suite 200
Cedar Park, TX 78613
T: 512-260-6050
Texas Oncology-Leander
505 St. David’s Loop, Suite 311
Leander, TX 78641
T: 512-260-6050

Metro Area: Austin

Spoken Language: English

Downloads

Biography

Education

Fellowship in Medical Oncology and Hematology
University of California, Los Angeles, Los Angeles, CA
Residency in Internal Medicine
University of California San Diego Medical Center, San Diego, CA
Internship in Internal Medicine
University of California San Diego, San Diego, CA
Medical Doctorate
Wayne State University, Detroit, MI

Accolades & Memberships

Resident Research Symposium Award, University of California at San Diego (2017)

Latest News

Publications

Perspectives on the Treatment of Advanced Thyroid Cancer: Ap-Proved Therapies, Resistance Mechanisms, and Future Directions
Frontiers in Oncology, 2021
Treatment of Metastatic Placental Site Trophoblastic Tumor With Surgery, Chemotherapy, Immunotherapy and Coil Embolization of Multiple Pulmonary Arteriovenous Fistulate
Gynecologic Oncology Reports, 2021
Selected as an Expert Consultant To Discuss Recent Data Related to Cutaneous Squamous Cell Carcinoma, Head and Neck Cancers, and Melanoma
ASCO, 2020
Exploring Updates in Head and Neck Cancer Research

ASCO Daily News, 2020
Combination Immunotherapy and Tki in Metastatic Recurrent Thyroid Cancer, a Case Series
ASCO-ASTRO Multidisciplinary HNC Symposium, 2020

Show all Publications

Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
Translational Cancer Research, 2020
Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
ASCO-ASTRO Multidisciplinary HNC Cancers Symposium, 2018
Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
UCSD Internal Medicine Grand Rounds, 2017
Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
UCSD Resident Research Symposium, 2017
Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
ASCO, 2017
Next Generation Sequencing of Cell Free Circulating Tumor DNA in Blood Samples of Recurrent and Metastatic Head and Neck Cancer Patients
AACR-American Head and Neck Society, 2017
Cell-Free Circulating Tumor DNA (ctDNA) in Hnc Patients: UCSD Experience to Date
Southern California Head and Neck Consortium, 2016
A Sloppy ‘Disappearing Act’: Clues in a Case of Candida Endocarditis
Society for Hospital Medicine, 2016
A Rare Case of Central Nervous System Tuberculosis
Case Reports in Infectious Diseases, 2014
A Rare Case of Central Nervous System Tuberculosis
Society for General Internal Medicine, 2014
Possible New Cancer Treatments: Ribosome Biogenesis as an Unexplored Target
Great Lakes Chapter of the American Society of Pharmacology and Experimental, 2009

Medical Practice

Gibbs Cancer Center, Spartanburg, SC (2021)

Other Information

Ashleigh Porter, M.D., is originally from Detroit, MI. In her free time, she loves trying new restaurants, traveling, and exploring the live music scene with her husband, an orthopedic surgeon, their great Dane Leon, and their corgi Lucy.